This article updates the Heart Failure Association of the European Society of Cardiology
(ESC) 2007 classification of advanced heart failure and describes new diagnostic and …

Ventricular assist device has rapidly emerged as a durable and safe therapy for end-stage
heart failure patients with> 22 000 implantations to date. Though originally conceived for …

Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

CO-CHAIRS: Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, Georgia
Institute of Technology and Morehouse School of Medicine; Pamboukian SV: University of …

Over 25 years ago, it became clear that heart transplantation would become a treatment
option for only a limited group of carefully selected patients with advanced heart failure (HF) …

See page 49 for disclosure information. List of abbreviations: ACT, activated clotting time;
aPTT, activated partial thromboplastin time; ACHD, adult congenital heart disease; ADHF …

Patients with infective endocarditis (IE) form a heterogeneous group, ranging from those
who are successfully treated with no adverse events, to those with severe complications and …

Mechanical circulatory support (MCS) evolved from an engineering dream to clinical reality
during the 1980s when increasing numbers of patients were dying on heart transplant wait …

Background—Ventricular assist devices (VADs) improve survival and quality of life in
patients with advanced heart failure, but their use is frequently complicated by infection …

Heart failure (HF) remains a major cause of morbidity and mortality. Heart transplantation
(HT) is a life-saving procedure for patients with advanced heart failure, but availability is …